Mastercard To $428? Plus This Analyst Slashes PT On Intel

  • Barclays cut the price target on Mastercard Incorporated MA from $430 to $428. Barclays analyst Ramsey El-Assal maintained an Overweight rating on the stock. Mastercard shares fell 0.6% to $327.42 in pre-market trading.
  • Citigroup cut the price target for Intel Corporation INTC from $30 to $27. Citigroup analyst Christopher Danely maintained a Neutral rating on the stock. Intel shares rose 0.2% to $29.12 in pre-market trading.
  • RBC Capital cut the price target on Amedisys, Inc. AMED from $165 to $139. Amedisys shares rose 5.3% to close at $97.63 on Friday.
  • Oppenheimer boosted the price target for BioMarin Pharmaceutical Inc. BMRN from $92 to $110. BioMarin Pharmaceutical shares rose 1.6% to $88.15 in pre-market trading.
  • B of A Securities raised the price target for First Solar, Inc. FSLR from $138 to $165. First Solar shares fell 0.4% to $132.16 in pre-market trading.
  • Wells Fargo slashed the price target on Lennox International Inc. LII from $249 to $238. Lennox shares gained 4.3% to close at $237.42 on Friday.
  • Credit Suisse raised the price target on AllianceBernstein Holding L.P. AB from $28 to $30. AllianceBernstein shares rose 4.9% to close at $37.25 on Friday.

Check out this: Chevron To Rally Around 21%? Here Are 5 Other Price Target Changes For Monday

Don’t forget to check out our premarket coverage here .

Market News and Data brought to you by Benzinga APIs
Price Target
Posted In: NewsPrice TargetPre-Market OutlookMarketsAnalyst RatingsTrading IdeasBuilding ProductsData Processing & Outsourced ServicesIndustrialsInformation TechnologyPT Changes
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!